BioPharma Drug Discovery
Results of pivotal confirmatory trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall survival and progres...
December 04, 2023 | News
ALINA is the first and only Phase III study to show an improvement in disease-free survival in patients from Asia with early-stage resected ALK-posit...
December 04, 2023 | News
At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced it is working with Accenture (NYSE: ACN...
November 30, 2023 | News
Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics®...
November 29, 2023 | News
Valneva's lyophilized chikungunya vaccine IXCHIQ® is the first in the world to be FDA approved against the viral disease, addressing an unm...
November 27, 2023 | News
--Nefecon® is the first approved medicine with an IgAN indication in China-- --The approval marks a new era of IgAN treatment for Chinese patient...
November 27, 2023 | News
“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...
November 23, 2023 | News
This marks a significant milestone as XEOMIN® is the first approved neurotoxin for the treatment of this condition in the Australian market. Addit...
November 23, 2023 | News
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
November 23, 2023 | News
The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether ...
November 22, 2023 | News
On June 30, 2023, the China National Medical Products Administration (NMPA) approved the marketing of Equecabtagene Autoleucel Injection (brand name: FUCAS...
November 22, 2023 | News
-Prospection—the pioneer of patient-centric intelligence—today announced the availability of Prospection AI, its self-service patient-cent...
November 21, 2023 | News
Early results presented at the Union World Conference on Lung Health suggest promise of new compound to fight tuberculosis that will be tested as part of P...
November 17, 2023 | News
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) have shattered scientific barriers today as the United Kingdom Me...
November 17, 2023 | News
Most Read
Bio Jobs
News
Editor Picks